DossierENTITY

Biocon

Coverage of Biocon in the Nexus archive.

Earliest in view: May 11 · 05:49 UTCMost recent: Jun 16 · 01:40 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJun 16 · 01:40 UTCBLOOMBERG
Biocon's Mazumdar Shaw Says Firm On Track To Be Top Insulin Maker
Biocon's Mazumdar Shaw stated the company is on track to become a leading insulin manufacturer. The firm aims to strengthen its position in the insulin market.
HEALTHMay 11 · 05:49 UTCBLOOMBERG
India's Biocon on Generic GLP-1 Push
Biocon is pushing for generic GLP-1, a significant development in India's pharmaceutical industry. The company's efforts aim to make this medication more accessible. Biocon's initiative has the potential to impact the Indian healthcare sector.